These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7636844)

  • 21. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
    Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
    Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding.
    Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A
    J Med Chem; 1991 Aug; 34(8):2521-4. PubMed ID: 1652021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
    Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
    Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
    J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
    Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studies.
    Natale NR; Triggle DJ; Palmer RB; Lefler BJ; Edwards WD
    J Med Chem; 1990 Aug; 33(8):2255-9. PubMed ID: 2142737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
    Navidpour L; Miri R; Shafiee A
    Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
    Jiang J; Li AH; Jang SY; Chang L; Melman N; Moro S; Ji X; Lobkovsky EB; Clardy JC; Jacobson KA
    J Med Chem; 1999 Aug; 42(16):3055-65. PubMed ID: 10447949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enantioselective syntheses and calcium channel modulating effects of (+)- and (-)-3-isopropyl 5-(4-methylphenethyll) 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyridinedicarboxylates.
    Iqbal N; Vo D; McEwen CA; Wolowyk MW; Knaus EE
    Chirality; 1994; 6(7):515-20. PubMed ID: 7986665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.
    Zarghi A; Derakhshandeh K; Roshanzamir F; Jorjani M; Rastegar H; Varmazyari M; Shafiee A
    Boll Chim Farm; 2002; 141(1):15-20. PubMed ID: 12064052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents.
    Zarghi A; Sadeghi H; Fassihi A; Faizi M; Shafiee A
    Farmaco; 2003 Nov; 58(11):1077-81. PubMed ID: 14572858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
    Shan R; Velazquez C; Knaus EE
    J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
    Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
    Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (manidipine) dihydrochloride.
    Kajino M; Wada Y; Nagai Y; Nagaoka A; Meguro K
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2225-8. PubMed ID: 2598325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Budriesi R; Ioan P; Locatelli A; Cosconati S; Leoni A; Ugenti MP; Andreani A; Di Toro R; Bedini A; Spampinato S; Marinelli L; Novellino E; Chiarini A
    J Med Chem; 2008 Mar; 51(6):1592-600. PubMed ID: 18303827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
    Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LY249933: a cardioselective 1,4-dihydropyridine with positive inotropic activity.
    Holland DR; Wikel JH; Kauffman RF; Smallwood JK; Zimmerman KM; Utterback BG; Turk JA; Steinberg MI
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):483-91. PubMed ID: 2476630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.